GLP-1RAs show favorable signal for reducing advanced liver outcomes in Type 2 Diabetes
Glucagon-like peptide-1 receptor agonists and advanced liver outcomes in type 2 diabetes: a systematic review and exploratory meta-analysis.
Abstract
GLP-1RAs demonstrate a favorable signal for reducing advanced liver outcomes in Type 2 Diabetes, with a 15% lower risk of cirrhosis or serious liver events vs. DPP-4 inhibitors (HR 0.85).